Author

J. C. McAuliffe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Entenberg· 2 shared Y. Wang· 2 shared A. Beck· 1 shared A. Jahangir· 1 shared A. Patel· 1 shared A. S. Harney· 1 shared B. C. Selvanesan· 1 shared C. Gravekamp· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Entenberg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Signaling events at TMEM doorways provide potential targets for inhibiting breast cancer dissemination

C. R. Surve, C. L. Duran, X. Ye, X. Chen, Y. Lin, A. S. Harney, Y. Wang, V. P. Sharma, E. R. Stanley, D. Cox, J. C. McAuliffe, D. Entenberg, M. H. Oktay, J. S. Condeelis

This study identifies CSF-1 signaling as a key mechanism in TMEM doorway function, showing its role in promoting vascular openings and tumor cell intravasation in breast cancer.

bioRxiv · Jan 8, 2024 · PreprintCancer Biology

Tumor-targeted delivery of childhood vaccine recall antigens by attenuated Listeria reduces pancreatic cancer

B. C. Selvanesan, D. Chandra, W. Quispe-Tintaya, A. Jahangir, A. Patel, K. Meena, R. Alberto Alves Da Silva, M. Friedman, J. Li, S. Siddiqui, S. K. Libutti, Z. Yuan, A. Beck, L. Tesfa, W. Koba, , C. Gravekamp

This study shows that delivering a childhood vaccine antigen via attenuated Listeria improves immunotherapy for pancreatic cancer by converting cold tumors into hot tumors and enhancing T cell activity.

bioRxiv · Jun 4, 2021 · PreprintImmunology